Story perspectives

Genetically Modified Salmonella and 2-MiCit Show Promise in Cancer Treatment

9/29/2025

44 5

Summary

Story summary

Engineered Salmonella bacteria triggered immune responses against tumors and reduced tumor growth in mice.
Research from Singapore and China explores using genetically modified bacteria as living drugs for cancer treatment.
Another study identified 2-methylisocitrate (2-MiCit) that enhances chemotherapy effectiveness against colorectal cancer.
2-MiCit disrupts cancer cell metabolism and works synergistically with 5-fluorouracil (5-FU), signaling potential but requiring further research.

1 of 1

Story summary

Engineered Salmonella bacteria triggered immune responses against tumors and reduced tumor growth in mice.
Research from Singapore and China explores using genetically modified bacteria as living drugs for cancer treatment.
Another study identified 2-methylisocitrate (2-MiCit) that enhances chemotherapy effectiveness against colorectal cancer.
2-MiCit disrupts cancer cell metabolism and works synergistically with 5-fluorouracil (5-FU), signaling potential but requiring further research.